Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Kaveh, Mehrvar"'
Autor:
Ashkan Mowla, Banafsheh Shakibajahromi, Shima Shahjouei, Humain Baharvahdat, Ali Amini Harandi, Farzad Rahmani, Stefania Mondello, Nasrin Rahimian, Achille Cernigliaro, Elyar Sadeghi Hokmabadi, Seyed Amir Ebrahimzadeh, Mahtab Ramezani, Kaveh Mehrvar, Mehdi Farhoudi, Soheil Naderi, Shahab Mahmoudnejad Fenderi, Masoud Pishjoo, Orkhan Alizada, Francisco Purroy, Manuel Requena, Georgios Tsivgoulis, Ramin Zand
Publikováno v:
Journal of the neurological sciences. 444
SARS-CoV-2 infection may be associated with uncommon complications such as intracerebral hemorrhage (ICH), with a high mortality rate. We compared a series of hospitalized ICH cases infected with SARS-CoV-2 with a non-SARS-CoV-2 infected control grou
Autor:
Elyar Sadeghi-Hokmabadi, Aliakbar Taheraghdam, Mazyar Hashemilar, Reza Rikhtegar, Kaveh Mehrvar, Mehrdad Mehrara, Reshad Mirnour, Rogayyeh Hassasi, Hannane Aliyar, Mohammadamin Farzi, Somayyeh Hasaneh Tamar
Publikováno v:
International Journal of Vascular Medicine, Vol 2016 (2016)
Background. Intravenous tissue plasminogen activator, a time dependent therapy, can reduce the morbidity and mortality of acute ischemic stroke. This study was designed to assess the effect of simple in-hospital interventions on reducing door-to-CT (
Externí odkaz:
https://doaj.org/article/d05e93c9cd72438b8a2ddcf92edc394e
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol 2010, Iss Issue 1, Pp 775-778 (2010)
Mehdi Farhoudi1, Kaveh Mehrvar2, Abbas Afrasiabi3, Rezayat Parvizi3, Ahmad Ali Khalili3, Babak Nasiri3, Khosrow Hashemzadeh3, Kamyar Ghabili41Neurosciences Research Center, Imam Reza Hospital, 2Razi Hospital, 3Cardiovascular Research Center, 4Tubercu
Externí odkaz:
https://doaj.org/article/79ab6d639b2047299befc12b62ae9783
Autor:
Birsen Ince, Kaveh Mehrvar, Mehdi Farhoudi, Gülçin Benbir Şenel, Mahsa Rezaei, Ayse Deniz Elmali, Mohammad Sadegh Aboutalebi
Publikováno v:
Iranian Journal of Neurology
Background: Multiple sclerosis (MS) is a neurologic disorder with a considerable global burden. During the last decades, some pharmaceutical treatments have been approved for patients with MS. Dimethyl fumarate (DMF) is one of these drugs which has b
Autor:
Hannane Aliyar, Mehrdad Mehrara, Reza Rikhtegar, Aliakbar Taheraghdam, Rogayyeh Hassasi, Reshad Mirnour, Mohammadamin Farzi, Somayyeh Hasaneh Tamar, Elyar Sadeghi-Hokmabadi, Mazyar Hashemilar, Kaveh Mehrvar
Publikováno v:
International Journal of Vascular Medicine
International Journal of Vascular Medicine, Vol 2016 (2016)
International Journal of Vascular Medicine, Vol 2016 (2016)
Background. Intravenous tissue plasminogen activator, a time dependent therapy, can reduce the morbidity and mortality of acute ischemic stroke. This study was designed to assess the effect of simple in-hospital interventions on reducing door-to-CT (
Autor:
Kaveh Mehrvar
Publikováno v:
Advances in Bioscience and Clinical Medicine, Vol 0, Iss 0 (2017)
Stroke is the leading cause of disability and the third leading cause of death . Anticoagulants have been used to treat patients with acute ischemic stroke for many years. Despite their widespread use, the usefulness of emergency anticoagulation is a
Publikováno v:
journal of experimental and clinical neuroscien.
Stroke is the second most common cause of death worldwide. Despite many advances in the field of vascular neurology, intravenous (IV) tissue plasminogen activator (tPA) remains the only approved treatment for acute ischemic stroke, even though compli
Autor:
Mehdi Farhoudi, Daryous Savadi-Osguei, Reza Rikhtegar, Elyar Sadeghi-Hokmabadi, Kaveh Mehrvar, Mazyar Hashemilar, Aliakbar Taheraghdam, Ehsan Sharifipour, Parisa Youhanaee, Reshad Mirnour
Publikováno v:
International Journal of General Medicine
Elyar Sadeghi-Hokmabadi, Mehdi Farhoudi, Aliakbar Taheraghdam, Mazyar Hashemilar, Daryous Savadi-Osguei, Reza Rikhtegar, Kaveh Mehrvar, Ehsan Sharifipour, Parisa Youhanaee, Reshad Mirnour Neurosciences Research Center, Neurology Department, Tabriz Un
Publikováno v:
Atherosclerosis Supplements. 32:141-142
Autor:
Naser Aslanabadi, Nazila Rasi Baghmishe, Kaveh Mehrvar, Kamyar Ghabili, Mehdi Farhoudi, Farzad Ilkhchoei
Publikováno v:
Vascular Health and Risk Management
Mehdi Farhoudi1, Kaveh Mehrvar2, Naser Aslanabadi3, Kamyar Ghabili1, Nazila Rasi Baghmishe4, Farzad Ilkhchoei41Neuroscience Research Center, 2Razi Hospital, 3Department of Cardiology, 4Faculty of Medicine, Tabriz University of Medical Sciences, Tabri